Genotypic and phenotypic characterization of hypertrophic cardiomyopathy at the Sociedad de Cirugía de Bogotá - Hospital de San José, Bogotá, 2023-2025
4 affiliations
- 1Departamento de Cardiología, Universidad FUCS Departamento de Cardiología Universidad FUCS
- 2Departamento de Medicina Interna, Universidad FUCS Departamento de Medicina Interna Universidad FUCS
- 3Vicerrectoría de Investigaciones, Universidad FUCS Vicerrectoría de Investigaciones Universidad FUCS
- 4Departamento de Cardiología y Electrofisiología, Universidad FUCS Departamento de Cardiología y Electrofisiología Universidad FUCS
Abstract
Objectives. : To characterise the clinical, imaging, and genetic profile of patients with hypertrophic cardiomyopathy treated at a university hospital in Bogotá between 2023 and 2025. To propose an institutional pathway for multimodal assessment and family screening, informed by the study findings and expert opinion.
Materials and methods.: We conducted a retrospective, cross-sectional observational study of adults treated at a university hospital, reported in accordance with the STROBE guidelines. We reviewed 182 medical records identified using International Classification of Diseases, 10th Revision (ICD-10) codes. After excluding 120 duplicate, repeated, incomplete, insufficient, or ineligible records, a convenience sample of 62 patients was included. Clinical, family history, imaging, and genetic variables were analysed using descriptive statistics and unadjusted exploratory comparisons according to genetic test results.
Results.: The median age was 69 years (interquartile range [IQR]: 46-75), and 50% of patients were women. Hypertension was the most common comorbidity (51.6%), and two patients had amyloidosis (3.2%). Asymmetrical septal hypertrophy was the predominant morphological pattern (27 of 46 patients; 58.7%). Both echocardiography and cardiac magnetic resonance imaging were available for 46.8% of patients. Median late gadolinium enhancement was 12%, and extensive fibrosis was observed in 6.5%. Genetic testing results were available for 47 patients (75.8%), of whom 10.6% had pathogenic or likely pathogenic variants. A family history of hypertrophic cardiomyopathy was more common in this group (p<0.001), which also had a higher left ventricular outflow tract gradient, a greater frequency of obstruction of 50 mmHg or more, systolic anterior motion of the mitral valve, and a higher left ventricular ejection fraction. Because only five patients had pathogenic or likely pathogenic variants, these comparisons were interpreted as exploratory.
Conclusions: . The cohort showed clinical, imaging, and genetic heterogeneity, with a high prevalence of hypertension and the presence of infiltrative phenocopies. These findings support the implementation of an institutional pathway integrating family pedigree assessment, echocardiography with strain imaging, cardiac magnetic resonance imaging with fibrosis quantification, clinical genetic evaluation, and family screening.
Related
- Artificial Intelligence-Enhanced Cardiac Magnetic Resonance in Hypertrophic Cardiomyopathy: Diagnosis, Phenotypic Characterization, and Risk Prediction
- Genotypic and Phenotypic Characterization of MRSA Colonization and Persistence in Residential Aged Care Facilities in Adelaide, Australia.
- Availability of genotypic and phenotypic drug susceptibility testing for Mycobacterium tuberculosis in WHO European Region
- A late bloom at the apex: development of apical hypertrophic cardiomyopathy phenotype in advanced age
- Research trends and hotspot analysis of sudden cardiac death in hypertrophic cardiomyopathy : A bibliometric analysis
BibTeX
@article{celycristancho2026genotypic,
title = {{Genotypic and phenotypic characterization of hypertrophic cardiomyopathy at the Sociedad de Cirugía de Bogotá - Hospital de San José, Bogotá, 2023-2025}},
author = {Héctor J. Cely-Cristancho and Diana Vargas-Vergara and Franklin David Rincón-Viloria and Fabián Cervantes de la Hoz and Alexander Casallas-Vega and Alejandro Olaya-Sánchez and Jorge Leonardo Fajardo-Ruge},
journal = {Archivos Peruanos de Cardiología y Cirugía Cardiovascular},
year = {2026},
month = sep,
doi = {10.47487/apcyccv.v7i3.649},
url = {https://doi.org/10.47487/apcyccv.v7i3.649},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Genotypic and phenotypic characterization of hypertrophic cardiomyopathy at the Sociedad de Cirugía de Bogotá - Hospital de San José, Bogotá, 2023-2025
AU - Héctor J. Cely-Cristancho
AU - Diana Vargas-Vergara
AU - Franklin David Rincón-Viloria
AU - Fabián Cervantes de la Hoz
AU - Alexander Casallas-Vega
AU - Alejandro Olaya-Sánchez
AU - Jorge Leonardo Fajardo-Ruge
PY - 2026
DA - 2026/09/26
JO - Archivos Peruanos de Cardiología y Cirugía Cardiovascular
DO - 10.47487/apcyccv.v7i3.649
UR - https://doi.org/10.47487/apcyccv.v7i3.649
AB - Objectives. : To characterise the clinical, imaging, and genetic profile of patients with hypertrophic cardiomyopathy treated at a university hospital in Bogotá between 2023 and 2025. To propose an institutional pathway for multimodal assessment and family screening, informed by the study findings and expert opinion. Materials and methods.: We conducted a retrospective, cross-sectional observational study of adults treated at a university hospital, reported in accordance with the STROBE guidelines. We reviewed 182 medical records identified using International Classification of Diseases, 10th Revision (ICD-10) codes. After excluding 120 duplicate, repeated, incomplete, insufficient, or ineligible records, a convenience sample of 62 patients was included. Clinical, family history, imaging, and genetic variables were analysed using descriptive statistics and unadjusted exploratory comparisons according to genetic test results. Results.: The median age was 69 years (interquartile range [IQR]: 46-75), and 50% of patients were women. Hypertension was the most common comorbidity (51.6%), and two patients had amyloidosis (3.2%). Asymmetrical septal hypertrophy was the predominant morphological pattern (27 of 46 patients; 58.7%). Both echocardiography and cardiac magnetic resonance imaging were available for 46.8% of patients. Median late gadolinium enhancement was 12%, and extensive fibrosis was observed in 6.5%. Genetic testing results were available for 47 patients (75.8%), of whom 10.6% had pathogenic or likely pathogenic variants. A family history of hypertrophic cardiomyopathy was more common in this group (p<0.001), which also had a higher left ventricular outflow tract gradient, a greater frequency of obstruction of 50 mmHg or more, systolic anterior motion of the mitral valve, and a higher left ventricular ejection fraction. Because only five patients had pathogenic or likely pathogenic variants, these comparisons were interpreted as exploratory. Conclusions: . The cohort showed clinical, imaging, and genetic heterogeneity, with a high prevalence of hypertension and the presence of infiltrative phenocopies. These findings support the implementation of an institutional pathway integrating family pedigree assessment, echocardiography with strain imaging, cardiac magnetic resonance imaging with fibrosis quantification, clinical genetic evaluation, and family screening.
SN - 2708-7212
ER -